ArticleJournal for immunotherapy of cancer2018

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.

Michael Lattanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.